“Naloxone is a critical tool in addressing opioid overdoses and today’s approval underscores the extensive efforts the agency has undertaken to combat the overdose crisis.”
Director of the FDA’s Center for Drug Evaluation and Research, Dr. Patrizia Cavazzoni. The FDA announced the approval of an over-the-counter nasal spray that helps prevent fatal opioid overdoses.
mar 29, 2023